The National Institutes of Health has named the California Precision Medicine Consortium as a regional medical center group in the national network of health care provider organizations that will implement the Precision Medicine Initiative Cohort Program.
The University of Southampton and Plasma App Limited have announced that they are collaborating in a one-year £150,000 feasibility study to explore novel thin film coating technology and applications.
A home appliance that grows the ingredients for a healthy meal within a week from plant cells is no longer science fiction.
The application Ahmes (whose name pays homage to the Ahmes Papyrus, also known as Rhind Mathematical Papyrus, written during the reign of Apophis I), developed by a group of Spanish scientists, measures the angle of a tree's leaves and calculates their position with respect to the sun.
The Minimally Invasive Urology Institute at the Miriam Hospital is now performing a completely laparoscopic surgery for the treatment of bladder cancer.
The academic partners in the VerICiguaT GlObal Study in Subjects with Heart Failure with Reduced EjectIon FrAction (VICTORIA) are pleased to announce that patient enrollment has begun. The study will explore a novel treatment pathway in patients suffering from chronic heart failure with reduced ejection fraction (HFrEF), by investigating the clinical impact of the drug vericiguat. VICTORIA is a pivotal Phase III clinical study conducted in collaboration with Merck and Bayer.
The Critical Materials Institute (CMI) -- a US Department of Energy Innovation Hub led by the Ames Laboratory 0- announced today an important new research initiative in partnership with Rio Tinto, a mining and metals company. The new initiative aims to ensure that the United States fully leverages domestic mineral and metal resources necessary for global leadership in clean energy manufacturing.
Funded by a grant from the European Partnership for Alternative Approaches to Animal Testing, the Institute for In Vitro Sciences, Inc. has released a technical training video that describes a cell-based in vitro method for assessing phototoxicity -- the potential for chemicals to cause damage after being exposed to light.
In an article outlining the methodology for an upcoming clinical trial, a multi-center team of researchers discuss the therapeutic potential and logistics of using a cluster of cardiac cells, including stem cells, called 'cardiosphere-derived cells' (CDCs) for myocardial infarction (MI -- commonly referred to as heart attack). The planned study will be a randomized, double-blind, placebo-controlled phase 1 and 2 study to determine the safety of CDC transplantation for treating MI.
The researchers behind a new online game are inviting members of the public to look under a virtual microscope and contribute directly to Alzheimer's disease research at Cornell University.